This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.
This is a single center, open label, pilot study. 5 adult patients, aged over 18, who are
confirmed positive with SARS-CoV-2 and are newly intubed, will receive UV light treatment to
reduce SARS-CoV-2 viral load.
Device: UV Light Treatment
UV light therapy administered while patient is mechanically ventilated
Inclusion Criteria:
- Confirmed positive test result for SARS-CoV-2
- Mechanically ventilated
- Endotracheal tube inner diameter of at least 7.5 mm
Exclusion Criteria:
- Unable to provide informed consent (or surrogate)
- Enrolled in a therapeutic clinical trial for same condition that does not allow
recruitment in other trials
- Pregnant women
Cedars-Sinai Medical Center
Los Angeles, California, United States
George Chaux, MD, Principal Investigator
Cedars-Sinai Medical Center